Skip to main content
Signal8

Helus Pharma Inc. (HELP)

Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

Helus Pharma Inc. Common Stock logo

Helus Pharma Inc. Common Stock

NASDAQ:HELPHealthcare
AH+0.64%$9.43
Close$9.37+4.58%
Mkt Cap$684.66M
Float50.07M
O/S73.07M
VOL1.6M sh
$ Vol$14.93M
RVOL1.04×
Inst Own42.5%
Dilution
Helus Pharma Inc. Common Stock logoNASDAQ:HELPAH$9.43+0.64%
FormDescription
6-K
Foreign Private Issuer Report
2
6-K
Foreign Private Issuer Report
3
Initial Statement of Beneficial Ownership
6-K
Foreign Private Issuer Report
3
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
6-K
Foreign Private Issuer Report
3
6-K
Foreign Private Issuer Report
2
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report
1
6-K
Foreign Private Issuer Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report
2
6-K
Foreign Private Issuer Report
4
Statement of Changes in Beneficial Ownership
6-K
Foreign Private Issuer Report
3
3
Initial Statement of Beneficial Ownership

1-25 of 453

…

Recent SEC filings with analysis